PAK2 Mouse Monoclonal Antibody [Clone ID: 3B5]
CAT#: AM06347SU-N
PAK2 mouse monoclonal antibody, clone 3B5, Ascites
Need it in bulk or conjugated?
Get a free quote
CNY 6050.00
货期*
5周
规格
| Cited in 1 publication. |
Specifications
| Product Data | |
| Clone Name | 3B5 |
| Applications | IF, IHC, WB |
| Recommend Dilution | ELISA: 1/10000. Western Bloting: 1/500 - 1/2000. Immunofluorescence: 1/200 - 1/1000. Immunohistochemistry on Paraffin Sections: 1/200 - 1/1000. |
| Reactivity | Human, Monkey |
| Host | Mouse |
| Clonality | Monoclonal |
| Immunogen | Purified recombinant fragment of PAK2 expressed in E. Coli. |
| Specificity | Recognizes PAK2 |
| Isotype | IgG1 |
| Formulation | State: Ascites State: Ascitic fluid containing 0.03% Sodium Azide. |
| Conjugation | Unconjugated |
| Storage Condition | Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. |
| Predicted Protein Size | 61 kDa |
| Gene Name | p21 (RAC1) activated kinase 2 |
| Database Link | |
| Background | PAK2, also known as P21 (CDKN1A)-activated kinase 2. The p21 activated kinases (PAK) are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. The PAK proteins are a family of serine/threonine kinases that serve as targets for the small GTP binding proteins, CDC42 and RAC1, and have been implicated in a wide range of biological activities. PAK2 is activated by proteolytic cleavage during caspase-mediated apoptosis, and may play a role in regulating the apoptotic events in the dying cell. PAK2 has been shown to interact with SH3KBP1, CDC42 and Abl gene. |
| Synonyms | PAK 2, PAK-2, Gamma-PAK, PAK gamma, PAK65, p21-activated kinase 2, p58 |
| Reference Data | |
Citations (1)
| The use of this Antibodies has been cited in the following citations: |
|---|
|
P21‐activated kinase 2 is essential in maintenance of peripheral Foxp3+ regulatory T cells
,null,
Immunology
,PubMed ID 29297928
[PAK2]
|
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
| 抗体相关资料 |
Customer
Reviews
Loading...
